Kezar Life Sciences, Inc. (KZR)

7.29 -0.07 (-0.95%) USD  |  NASDAQ  |  May 08, 16:00
7.41 +0.12 (+1.65%) After-Hours: 17:04
More

Kezar Life Sciences EPS Diluted (Quarterly) : -1.985 for Dec. 31, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for KZR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Apellis Pharmaceuticals, Inc. -0.4654
ACADIA Pharmaceuticals, Inc. 1.596
Alnylam Pharmaceuticals, Inc. 1.508
Savara, Inc. -0.1341
BioMarin Pharmaceutical, Inc. 0.5431

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -14.55M
Total Expenses (Quarterly) 14.55M
Enterprise Value -15.30M
Earnings Yield -105.1%
Normalized Earnings Yield -95.91